Jabłonowska-Babij Paula, Jędrzejuk Diana, Majcherek Maciej, Szeremet Agnieszka, Karasek Magdalena, Kuszczak Bartłomiej, Kujawa Krzysztof, Sitkiewicz Milena, Landwójtowicz Marcin, Wróbel Tomasz, Tomasiewicz Maciej, Czyż Anna
Department and Clinic of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, 50-367 Wroclaw, Poland.
Department and Clinic of Endocrinology, Diabetology, and Isotope Therapy, Wroclaw Medical University, 50-367 Wroclaw, Poland.
J Clin Med. 2024 Oct 8;13(19):5987. doi: 10.3390/jcm13195987.
: Changes in muscle mass and bone density are common in multiple myeloma (MM) patients. Dual-energy X-ray absorptiometry (DXA) offers precise, non-invasive insights into a patient's physical condition before autologous stem cell transplantation (autoHSCT). This study examines how pre-transplant body composition impacts treatment outcomes and early complications in MM patients undergoing autoHSCT. : This study is a single-center, retrospective analysis of patients with MM who were treated with first or second autoHSCT and underwent DXA pre-transplant between 11 August 2019 and 12 June 2024. : We conducted a study of pre-transplant body composition in 127 patients with MM. Among them, 108 (85%) qualified for first autoHSCT, while 19 (15%) qualified for a second. The median age of the patients was 64 years (range 50-73). In the Cox proportional hazards regression conducted in the group of women, Total Body %Fat was a statistically significant predictor for progression-free survival (PFS) (HR = 0.07, 95% CI = 0.01,0.6, = 0.0157). In the Mann-Whitney U test conducted on males, Lean Mass/Height and Appen. Lean Height were statistically significant predictors of early infections after autoHSCT (Z = 1.98, = 0.0473 and Z = 2.32, = 0.0204, respectively). In males, Fat Mass/Height was a significant predictor of non-infectious toxicity related to treatment (Z = -1.98, = 0.0476). : In women, higher levels of adipose tissue initially appear to exert a protective effect; however, this benefit diminishes over time, with greater fat mass eventually correlating with an increased risk of disease progression. In men, muscle mass has been identified as a significant predictor of early infection risk post-autoHSCT. Furthermore, our findings indicate that an increased amount of adipose tissue in men is statistically associated with a higher risk of non-infectious treatment-related toxicity. These conclusions highlight the critical need for further investigation into the role of body composition.
肌肉量和骨密度的变化在多发性骨髓瘤(MM)患者中很常见。双能X线吸收法(DXA)能在自体干细胞移植(autoHSCT)前为患者的身体状况提供精确、无创的深入了解。本研究探讨移植前身体成分如何影响接受autoHSCT的MM患者的治疗结果和早期并发症。 本研究是一项单中心回顾性分析,研究对象为接受首次或第二次autoHSCT治疗且在2019年8月11日至2024年6月12日期间移植前接受DXA检查的MM患者。 我们对127例MM患者的移植前身体成分进行了研究。其中,108例(85%)符合首次autoHSCT条件,19例(15%)符合第二次autoHSCT条件。患者的中位年龄为64岁(范围50 - 73岁)。在对女性组进行的Cox比例风险回归分析中,全身脂肪百分比是无进展生存期(PFS)的统计学显著预测因素(HR = 0.07,95% CI = 0.01,0.6,P = 0.0157)。在对男性进行的Mann-Whitney U检验中,瘦体重/身高和阑尾瘦身高是autoHSCT后早期感染的统计学显著预测因素(Z = 1.98,P = 0.0473和Z = 2.32,P = 0.0204)。在男性中,脂肪量/身高是与治疗相关的非感染性毒性的显著预测因素(Z = -1.98,P = 0.0476)。 在女性中,较高水平的脂肪组织最初似乎具有保护作用;然而,这种益处会随着时间的推移而减弱,最终更高的脂肪量与疾病进展风险增加相关。在男性中,肌肉量已被确定为autoHSCT后早期感染风险的显著预测因素。此外,我们的研究结果表明,男性体内脂肪组织量增加在统计学上与更高的非感染性治疗相关毒性风险相关。这些结论凸显了进一步研究身体成分作用的迫切需求。